Cargando…
Radiation and Dose-densification of R-CHOP in Primary Mediastinal B-cell Lymphoma: Subgroup Analysis of the UNFOLDER Trial
UNFOLDER (NCT00278408, EUDRACT 2005-005218-19) is a phase-3 trial in patients with aggressive B-cell lymphoma and intermediate prognosis, including primary mediastinal B-cell lymphoma (PMBCL). In a 2 × 2 factorial design, patients were randomized to 6× R-CHOP-14 or R-CHOP-21 (rituximab, cyclophospha...
Autores principales: | Held, Gerhard, Thurner, Lorenz, Poeschel, Viola, Ott, German, Schmidt, Christian, Christofyllakis, Konstantinos, Viardot, Andreas, Borchmann, Peter, Engel-Riedel, Walburga, Frickhofen, Norbert, Nickelsen, Maike, Shpilberg, Ofer, Witzens-Harig, Mathias, Griesinger, Frank, Krammer-Steiner, Beate, Neubauer, Andreas, de Nully Brown, Peter, Federico, Massimo, Glass, Bertram, Schmitz, Norbert, Wulf, Gerald, Truemper, Lorenz, Bewarder, Moritz, Murawski, Niels, Stilgenbauer, Stephan, Rosenwald, Andreas, Altmann, Bettina, Engelhard, Marianne, Schmidberger, Heinz, Fleckenstein, Jochen, Berdel, Christian, Loeffler, Markus, Ziepert, Marita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10325764/ https://www.ncbi.nlm.nih.gov/pubmed/37427145 http://dx.doi.org/10.1097/HS9.0000000000000917 |
Ejemplares similares
-
Radiation and Dose-densification of R-CHOP in Aggressive B-cell Lymphoma With Intermediate Prognosis: The UNFOLDER Study
por: Thurner, Lorenz, et al.
Publicado: (2023) -
Impact of vincristine dose reduction on outcomes of patients with aggressive B-cell lymphoma treated with (R)-CHOP
por: Bewarder, Moritz, et al.
Publicado: (2023) -
First-line Treatment With Bendamustine and Rituximab for Old and Frail Patients With Aggressive Lymphoma: Results of the B-R-ENDA Trial
por: Braulke, Friederike, et al.
Publicado: (2022) -
Low serum albumin is an independent risk factor in elderly patients with aggressive B‐cell lymphoma: Results from prospective trials of the German High‐Grade Non‐Hodgkin's Lymphoma Study Group
por: Hohloch, Karin, et al.
Publicado: (2020) -
FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma: results from the prospective, multicenter PETAL and OPTIMAL>60 trials
por: Kaddu-Mulindwa, Dominic, et al.
Publicado: (2021)